Related Experiment Video
Updated: Jul 23, 2025

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
Published on: March 10, 2016
Innate Immunity, Epithelial Plasticity, and Remodeling in Asthma
1Department of Medicine and Institute for Clinical and Translational Research (ICTR), School of Medicine and Public Health (SMPH), University of Wisconsin-Madison, Madison, WI, USA. abrasier@wisc.edu.
Asthma involves innate immune responses in airway epithelium. Chronic activation leads to epithelial-mesenchymal plasticity (EMP), a process linked to airway remodeling and offering new therapeutic targets.
Area of Science:
- Immunology
- Cell Biology
- Pulmonology
Background:
- Epithelial innate immune responses (IIR) are crucial in asthma initiation and progression.
- Pattern recognition receptors (PRRs) activate intracellular signaling pathways central to IIR.
- The epithelium acts as a key innate sentinel cell, particularly in acute asthma exacerbations.
Purpose of the Study:
- To explore the role of epithelial IIR in asthma, focusing on acute exacerbations.
- To elucidate the mechanisms linking chronic IIR activation to mucosal adaptive responses.
- To investigate epithelial-mesenchymal plasticity (EMP) as a response to airway injury and remodeling.
Main Methods:
- Review of existing literature on IIR, NFκB signaling, and Th2 polarization.
- Analysis of recent research on the link between chronic IIR and adaptive immune responses.
- Examination of the role of unfolded protein response (UPR) and hexosamine biosynthetic pathway (HBP) in EMP.
Main Results:
- Chronic IIR activation is mechanistically linked to mucosal adaptive responses.
- Epithelial-mesenchymal plasticity (EMP) is a genomic response to airway injury, involving barrier disruption and remodeling.
- NFκB and UPR pathways interact to remodel the basement membrane.
Conclusions:
- Understanding epithelial injury-repair processes offers novel therapeutic targets for asthma.
- Targeting the interplay between IIR, EMP, and UPR may provide precision approaches for asthma exacerbations.
- EMP, driven by UPR and HBP, is a key adaptation in chronic airway remodeling.
More Related Videos
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
07:40Determining Ciliary Function and Membrane Impermeability of the Pseudostratified Lung Airway Epithelium
Published on: February 21, 2025
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-III: Symptoms and Complications
Classification of Asthma